BNP Paribas Financial Markets’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,920
| Closed | -$325K | – | 5129 |
|
|
2022
Q2 | $325K | Sell |
9,920
-2,385
| -19% | -$75.4K | ﹤0.01% | 2876 |
|
|
2022
Q1 | $323K | Sell |
12,305
-11,086
| -47% | -$271K | ﹤0.01% | 2961 |
|
|
2021
Q4 | $555K | Sell |
23,391
-12,281
| -34% | -$303K | ﹤0.01% | 2956 |
|
|
2021
Q3 | $895K | Buy |
35,672
+20,378
| +133% | +$519K | ﹤0.01% | 2445 |
|
|
2021
Q2 | $397K | Buy |
15,294
+1,944
| +15% | +$52.9K | ﹤0.01% | 2638 |
|
|
2021
Q1 | $342K | Buy |
13,350
+5,763
| +76% | +$148K | ﹤0.01% | 2785 |
|
|
2020
Q4 | $152K | Sell |
7,587
-947
| -11% | -$18.5K | ﹤0.01% | 3010 |
|
|
2020
Q3 | $146K | Buy |
8,534
+6,074
| +247% | +$115K | ﹤0.01% | 2904 |
|
|
2020
Q2 | $53.7K | Sell |
2,460
-11,402
| -82% | -$261K | ﹤0.01% | 3004 |
|
|
2020
Q1 | $321K | Buy |
13,862
+5,889
| +74% | +$171K | ﹤0.01% | 2607 |
|
|
2019
Q4 | $263K | Buy |
7,973
+2,352
| +42% | +$75.4K | ﹤0.01% | 2829 |
|
|
2019
Q3 | $179K | Buy |
5,621
+783
| +16% | +$22.8K | ﹤0.01% | 2813 |
|
|
2019
Q2 | $124K | Sell |
4,838
-2,342
| -33% | -$59.7K | ﹤0.01% | 2903 |
|
|
2019
Q1 | $182K | Sell |
7,180
-300,953
| -98% | -$8.98M | ﹤0.01% | 2763 |
|
|
2018
Q4 | $10.5M | Buy |
308,133
+271,176
| +734% | +$8.82M | 0.02% | 618 |
|
|
2018
Q3 | $1.32M | Buy |
36,957
+32,422
| +715% | +$1.14M | ﹤0.01% | 1643 |
|
|
2018
Q2 | $156K | Sell |
4,535
-5,742
| -56% | -$201K | ﹤0.01% | 2562 |
|
|
2018
Q1 | $346K | Sell |
10,277
-2,607
| -20% | -$82.5K | ﹤0.01% | 2453 |
|
|
2017
Q4 | $492K | Sell |
12,884
-4,361
| -25% | -$174K | ﹤0.01% | 2485 |
|
|
2017
Q3 | $647K | Buy |
17,245
+6,073
| +54% | +$214K | ﹤0.01% | 1842 |
|
|
2017
Q2 | $417K | Buy |
11,172
+4,690
| +72% | +$169K | ﹤0.01% | 2010 |
|
|
2017
Q1 | $254K | Sell |
6,482
-527
| -8% | -$19.8K | ﹤0.01% | 2114 |
|
|
2016
Q4 | $244K | Buy |
7,009
+2,243
| +47% | +$88.1K | ﹤0.01% | 2094 |
|
|
2016
Q3 | $187K | Sell |
4,766
-5,550
| -54% | -$221K | ﹤0.01% | 1785 |
|
|
2016
Q2 | $390K | Buy |
10,316
+5,643
| +121% | +$189K | ﹤0.01% | 1624 |
|
|
2016
Q1 | $180K | Sell |
4,673
-1,605
| -26% | -$59.8K | ﹤0.01% | 1580 |
|
|
2015
Q4 | $302K | Sell |
6,278
-657
| -9% | -$30.4K | ﹤0.01% | 1667 |
|
|
2015
Q3 | $274K | Buy |
6,935
+4,192
| +153% | +$178K | ﹤0.01% | 1744 |
|
|
2015
Q2 | $117K | Buy |
2,743
+1,986
| +262% | +$79.1K | ﹤0.01% | 1999 |
|
|
2015
Q1 | $29.9K | Buy |
+757
| New | +$27.9K | ﹤0.01% | 2172 |
|
|
2014
Q4 | – | Sell |
-1,890
| Closed | -$55.8K | – | 3441 |
|
|
2014
Q3 | $55.8K | Buy |
1,890
+1,888
| +94,400% | +$52.1K | ﹤0.01% | 2532 |
|
|
2014
Q2 | $50 | Buy |
+2
| New | +$49 | ﹤0.01% | 3784 |
|
|
2014
Q1 | – | Sell |
-394
| Closed | -$8.87K | – | 3913 |
|
|
2013
Q4 | $8.87K | Buy |
+394
| New | +$7.61K | ﹤0.01% | 2718 |
|
|
2013
Q3 | – | Sell |
-10,505
| Closed | -$143K | – | 2763 |
|
|
2013
Q2 | $143K | Buy |
+10,505
| New | +$143K | ﹤0.01% | 2453 |
|
Other funds holding NTUS
BNP Paribas Financial Markets's NTUS Position: Q3 2022 in Review
BNP Paribas Financial Markets sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 9,920 shares — an estimated $325K sold.
BNP Paribas Financial Markets first reported a position in NTUS in Q2 2013 and held it in 34 quarters. The position peaked at $10.5M in Q4 2018. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- BNP Paribas Financial Markets reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 9,920 Natus Medical Inc shares in Q3 2022, an estimated $325K.
- BNP Paribas Financial Markets first reported a position in Natus Medical Inc in Q2 2013 and held it in 34 quarters.
- BNP Paribas Financial Markets's Natus Medical Inc position peaked at $10.5M in Q4 2018.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2022, filed 15 Nov 2022.